Heart Test Laboratories I...
0.04
-0.01 (-20.00%)
At close: Jan 15, 2025, 11:27 AM
0.04
0.00%
Pre-market Jan 15, 2025, 11:27 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY24 FY23 FY22 FY21 FY20
Net Income -6.61M -6.35M -4.83M -2.45M -3.81M
Depreciation & Amortization 95.13K 26.91K 26.57K 33.61K 63.83K
Stock-Based Compensation 405.02K 248.31K 68.40K 24.68K 135.07K
Other Working Capital -368.36K 136.06K 691.47K 104.54K -30.34K
Other Non-Cash Items 539.23K -100.97M -35.59K -248.54K -21.79K
Deferred Income Tax n/a 101.10M n/a n/a -10.02K
Change in Working Capital -504.36K 173.98K 1.12M 190.13K -195.97K
Operating Cash Flow -6.07M -5.77M -3.64M -2.45M -3.84M
Capital Expenditures -125.27K -18.31K -1.93K -712 -11.42K
Acquisitions n/a n/a n/a n/a 19.59K
Purchase of Investments n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a
Other Investing Acitivies -60.82K n/a n/a n/a 19.59K
Investing Cash Flow -125.27K -18.31K -1.93K -712 8.17K
Debt Repayment 42.62K -398.26K 4.23M 2.48M 633.79K
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies n/a 1.31M -385.14K 200.00K 1.18M
Financial Cash Flow 10.34M 6.53M 3.84M 2.68M 1.81M
Net Cash Flow 4.15M 742.21K 194.78K 226.63K -2.02M
Free Cash Flow -6.20M -5.79M -3.65M -2.45M -3.85M